| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |